Salbutamol Nebule Dosage for Pediatric Patients with Cough and History of Asthma

Dosing Recommendations

The French Anesthesia guidelines specifically recommend nebulized salbutamol at a dose of 2.5 mg for children weighing less than 20 kg and 5 mg for children weighing over 20 kg 1, 2
For acute asthma exacerbations, the American Thoracic Society recommends nebulized salbutamol at a dose of 5 mg for older children and half this dose (2.5 mg) for very young children 3
Administration should occur approximately 30 minutes before any procedures requiring anesthesia in children with respiratory symptoms 1

Salbutamol nebulization is a non-invasive, non-painful, and cost-effective therapy with minimal side effects 1
In children with respiratory symptoms and history of asthma, premedication with salbutamol has been shown to reduce perioperative cough and bronchospasm by approximately 50% 1
Compared to placebo, salbutamol premedication limits the increase in airway resistance observed after tracheal intubation in asthmatic children 1

For acute exacerbations, salbutamol should be delivered via oxygen-driven nebulizer when possible 3
In cases of moderate to severe symptoms, consider combining salbutamol with ipratropium bromide (100 mg nebulized every 6 hours) for enhanced bronchodilation 3

Monitor oxygen saturation continuously to maintain SaO₂ >92% during acute episodes 3
For patients with acute severe symptoms, consider measuring peak expiratory flow 15-30 minutes after starting treatment (if age-appropriate) 3
Chart peak expiratory flow before and after β-agonist administration in children old enough to perform the test 3

In children with uncontrolled asthma, ensure proper inhaler technique and medication adherence before adjusting therapy 4

Avoid overreliance on short-acting beta-agonists without adequate controller medications in children with persistent asthma 4
Do not delay administration of corticosteroids in acute exacerbations; they should be given concurrently with salbutamol 3, 4
Avoid inadequate assessment of inhaler technique, which can lead to suboptimal medication delivery 4
Do not use lidocaine (IV or topical) at induction to decrease respiratory adverse events in children with respiratory symptoms, as this is not recommended 1